F
Fengyan Yu
Researcher at Sun Yat-sen University
Publications - 27
Citations - 4319
Fengyan Yu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Breast cancer & Metastasis. The author has an hindex of 17, co-authored 24 publications receiving 3996 citations. Previous affiliations of Fengyan Yu include Harvard University.
Papers
More filters
Journal ArticleDOI
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Fengyan Yu,Fengyan Yu,Herui Yao,Pengcheng Zhu,Xiaoqin Zhang,Qiuhui Pan,Chang Gong,Yijun Huang,Xiaoqu Hu,Fengxi Su,Judy Lieberman,Erwei Song +11 more
TL;DR: Let-7 regulates multiple BT-IC stem cell-like properties by silencing more than one target, and miRNA expression in self-renewing and differentiated cells from breast cancer lines and in breast T-IC and non-BT-IC from 1 degrees breast cancers is compared.
Journal ArticleDOI
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Jingqi Chen,Jingqi Chen,Yandan Yao,Chang Gong,Fengyan Yu,Shicheng Su,Jianing Chen,Bodu Liu,Hui Deng,Fengsong Wang,Ling Lin,Herui Yao,Fengxi Su,Karen S. Anderson,Qiang Liu,Qiang Liu,Mark E. Ewen,Xuebiao Yao,Erwei Song +18 more
TL;DR: In this article, the authors show that breast TAMs abundantly produce CCL18, and its expression in blood or cancer stroma is associated with metastasis and reduced patient survival.
Journal ArticleDOI
miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
Derek M. Dykxhoorn,Yichao Wu,Huangming Xie,Fengyan Yu,Fengyan Yu,Ashish Lal,Fabio Petrocca,Denis Martinvalet,Erwei Song,Bing Lim,Bing Lim,Judy Lieberman +11 more
TL;DR: Expression of miR-200, which promotes a mesenchymal to epithelial cell transition (MET) by inhibiting Zeb2 expression, unexpectedly enhances macroscopic metastases in mouse breast cancer cell lines, suggesting that for some tumors, tumor colonization at metastatic sites might be enhanced by MET.
Journal ArticleDOI
Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
TL;DR: The data suggest mir-30 as one of the important miRNAs in regulating the stem-like features of T-ICs, which have a pivotal role in tumorigenesis, tumor progression, metastasis and post-treatment relapse.
Journal ArticleDOI
Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Yinghua Zhu,Fengyan Yu,Yu Jiao,Juan Feng,Wei Tang,Herui Yao,Chang Gong,Jianing Chen,Feng-xi Su,Yan Zhang,Erwei Song +10 more
TL;DR: Reduction in miR-128 leading to Bmi-1 and ABCC5 overexpression is a stem cell–like feature of BT-ICs, which contributes to chemotherapeutic resistance in breast cancers.